Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 30, 2007. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding insider trading and does not contain financial performance data.
Material Changes
The only material change reported is a transaction by Mr. J Clarke, a Person Discharging Managerial Responsibility. He sold 7,746 Ordinary shares at a price of GBP 12.80 per share on November 30, 2007. The company was advised of this transaction on the same date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Mr. J Clarke sold 7,746 shares of GlaxoSmithKline plc on November 30, 2007.
- The transaction price was GBP 12.80 per share.
- The filing confirms compliance with Disclosure and Transparency Rule 3.1.4R(1)(a).
- No financial performance metrics are included in this specific report.